Leishmaniasis: Current Status of Vaccine Development
نویسندگان
چکیده
منابع مشابه
Leishmaniasis: Current Status of Vaccine Development
INTRODUCTION .......................................................................................................................................................229 Clinical Leishmaniasis ...........................................................................................................................................229 Self-limiting cutaneous and visceral leishmaniasis ...............
متن کاملLeishmaniasis: Current Status of Vaccine Development
INTRODUCTION .......................................................................................................................................................229 Clinical Leishmaniasis ...........................................................................................................................................229 Self-limiting cutaneous and visceral leishmaniasis ...............
متن کاملLeishmaniasis: current status of vaccine development.
Leishmaniasis, a spectrum of diseases caused by various forms of Leishmania has become a major health problem all over the world. Vaccination against leishmaniasis has passed through many developmental stages beginning with the ancient practice of 'leishmanization'. Due to various problems and difficulties associated with traditional vaccines, the interest has been shifted to novel approaches o...
متن کامل“Current Dengue Vaccine Status”
As the impact of dengue expands, a safe and effective vaccine will benefit the world greatly. Recent progress and novel approaches have advanced the field, but many challenges and unanswered questions remain for dengue vaccine developers. The most advanced dengue vaccine candidate, a chimeric yellow fever dengue (CYD) tetravalent vaccine, was the first dengue vaccine tested in a field efficacy ...
متن کاملNontyphoidal salmonella disease: Current status of vaccine research and development.
Among more than 2500 nontyphoidal Salmonella enterica (NTS) serovars, S. enterica serovar Typhimurium and S. enterica serovar Enteritidis account for approximately fifty percent of all human isolates of NTS reported globally. The global incidence of NTS gastroenteritis in 2010 was estimated to be 93 million cases, approximately 80 million of which were contracted via food-borne transmission. It...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Microbiology Reviews
سال: 2001
ISSN: 0893-8512,1098-6618
DOI: 10.1128/cmr.14.2.229-243.2001